EGF and atrial fibrillation: Classification of persistent AF subtypes based on EGF signatures may help to differentiate those patients with source‐independent AF who would benefit from PVI‐alone (C‐type EGF signatures) versus those with source‐dependent AF requiring PVI plus targeted ablation of their active, clinically relevant extra‐PV sources (S‐type EGF signatures) to improve clinical outcomes.